X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Diabetes Technology & Therapeutics

期刊標題檢索 DIABETES TECHNO 最新評論: Journal HomepageWebsite: http://www.liebertpub.com/dia/Online submiss... (2013-06-20)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Diabetes Technology & Therapeutics]您好,您是該頁面的第 20584 位訪客。

期刊簡介
期刊名稱Diabetes Technology & Therapeutics Diabetes Technology & Therapeutics
LetPub Score
7.3
50 ratings
Rate

Reputation
8.6

Influence
6.3

Speed
7.0

期刊簡稱DIABETES TECHNOL THE
ISSN1520-9156
E-ISSN1557-8593
h-index79
CiteScore
CiteScoreSJRSNIPCiteScore Rank
10.602.9571.557
Subject fieldQuartilesRankPercentile
Category: Health Professions
Subcategory: Medical Laboratory Technology
Q11 / 41
Category: Health Professions
Subcategory: Endocrinology, Diabetes and Metabolism
Q127 / 244
Category: Health Professions
Subcategory: Endocrinology
Q118 / 128

自引率 (2023-2024)17.50%自引率趨勢
掲載範囲
Diabetes Technology & Therapeutics is the only peer-reviewed journal providing healthcare professionals with information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes. This leading international journal delivers practical information and comprehensive coverage of cutting-edge technologies and therapeutics in the field, and each issue highlights new pharmacological and device developments to optimize patient care.
官方網站http://www.liebertpub.com/overview/diabetes-technology-and-therapeutics/11/
在線稿件提交http://www.liebertpub.com/manuscript/diabetes-technology-and-therapeutics/11/
開放訪問No
出版商Mary Ann Liebert Inc.
主題領域医学
出版國/地區UNITED STATES
發行頻率月刊
創刊年1999
每年文章數112每年文章數趨勢
黃金OA百分比21.31%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ENDOCRINOLOGY & METABOLISMSCIEQ125/186
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1520-9156%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Ordinary, 3-8 Week(s)
競爭力 *來自作者的數據: Easy
參考鏈接
相關期刊 【Diabetes Technology & Therapeutics】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Nature Reviews EndocrinologyH-index: 116

    CiteScore: 42.00
    Cell MetabolismH-index: 219

    CiteScore: 48.60
    ENDOCRINE REVIEWSH-index: 257

    CiteScore: 42.00
    DIABETES CAREH-index: 328

    CiteScore: 29.50
    TRENDS IN ENDOCRINOLOGY AND METABOLISMH-index: 146

    CiteScore: 20.10
    METABOLISM-CLINICAL AND EXPERIMENTALH-index: 122

    CiteScore: 18.90
    Cardiovascular DiabetologyH-index: 64

    CiteScore: 12.30
    DIABETOLOGIAH-index: 207

    CiteScore: 18.10
    JOURNAL OF PINEAL RESEARCHH-index: 113

    CiteScore: 17.70
    Obesity ReviewsH-index: 137

    CiteScore: 19.30
    學科內最受檢索的期刊 頁面查看次數
    FREE RADICAL BIOLOGY AND MEDICINE191809
    Cell Metabolism129866
    DIABETES101921
    JOURNAL OF PINEAL RESEARCH98506
    BIOLOGICAL TRACE ELEMENT RESEARCH92871
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM81294
    ANTIOXIDANTS & REDOX SIGNALING79922
    DIABETES CARE73473
    BONE70440
    Obesity68345
  •  

    Diabetes Technology & Therapeutics Diabetes Technology & Therapeutics
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Diabetes Technology & Therapeutics] 的評論撰寫評論
作者: 匿名


領域:
審稿時間: 0.0 month(s)
結果:


撰寫評論

2013-06-20 13:29:00 評論於
Journal HomepageWebsite: http://www.liebertpub.com/dia/Online submission URL: http://mc.manuscriptcentral.com/diabetestechnology
(0) 讚! | 匿名

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Diabetes Technology & Therapeutics] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*